A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer

Fengying Wu,Shijia Zhang,Anwen Xiong,Guanghui Gao,Wei Li,Weijing Cai,Chunxia Su,Xiaoxia Chen,Fei Zhou,Jing Zhao,Shengxiang Ren,Caicun Zhou

Clinical Lung Cancer（2018）

引用 57|浏览24

暂无评分

摘要

Apatinib shows promising efficacy and manageable toxicity in patients with advanced non-squamous non-small-cell lung cancer. Apatinib therapy beyond progression could provide further benefits in specific subpopulations.

查看译文

关键词

Anti-angiogenesis,NSCLC,Targeted therapy,VEGFR-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要